• 1
    Sollid LM. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002; 2:647655.
  • 2
    Husby S, Koletzko S, Korponay-Szabó IR et al. for the ESPGHAN Working Group on Coeliac Disease Diagnosis, on behalf of the ESPGHAN Gastroenterology Committee, European Society for Pediatric Gastroenterology, Hepatology, and Nutrition. Guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012; 54:136160.
  • 3
    Oberhuber G, Granditsch G, Vogelsang H. The histopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999; 11:11851194.
  • 4
    Giersiepen K, Lelgemann M, Stuhldreher N et al. for the ESPGHAN Working Group on Coeliac Disease Diagnosis. Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report. J Pediatr Gastroenterol Nutr 2012; 54:229241.
  • 5
    Dieterich W, Ehnis T, Bauer M et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3:797801.
  • 6
    Marzari R, Sblattero D, Florian F et al. Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease. J Immunol 2001; 166:41704176.
  • 7
    Korponay-Szabo IR, Halttunen T, Szalai Z et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004; 53:641648.
  • 8
    Maglio M, Tosco A, Auricchio R et al. Intestinal deposits of anti-tissue transglutaminase IgA in childhood celiac disease. Dig Liver Dis 2011; 43:604608.
  • 9
    Ludvigsson JF, Leffler DA, Bai JC et al. The Oslo definitions for coeliac disease and related terms. Gut 2012; in press. [Epub ahead of print].
  • 10
    Tosco A, Salvati MV, Auricchio R et al. Natural history of potential celiac disease in children. Clin Gastroenterol Hepatol 2010; 9:320325.
  • 11
    Picarelli A, Maiuri L, Frate A et al. Production of antiendomysial antibodies after in-vitro gliadin challenge of small intestine biopsy samples from patients with coeliac disease. Lancet 1996; 348:10651067.
  • 12
    Vogelsang H, Schwarzenhofer M, Granditsch G et al. In vitro production of endomysial antibodies in cultured duodenal mucosa from patients with celiac disease. Am J Gastroenterol 1999; 94:10571061.
    Direct Link:
  • 13
    Carroccio A, Iacono G, D'Amico D et al. Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis. Scand J Gastroenterol 2002; 37:3238.
  • 14
    Picarelli A, Di Tola M, Sabbatella L et al. Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study. Scand J Gastroenterol 2006; 41:186190.
  • 15
    Carroccio A, Di Prima L, Pirrone G et al. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin Chem 2006; 52:11751180.
  • 16
    Stenman SM, Lindfors K, Korponay-Szabo IR et al. Secretion of celiac disease antibodies after in vitro gladin challenge is dependent on small-bowel mucosal transglutaminase2-specific IgA deposits. BMC Immunol 2008; 9:6. doi: 10.1186/1471-2172-9-6.
  • 17
    Picarelli A, Libanori V, De Nitto D et al. Organ culture system as a means to detect celiac disease. Ann Clin Lab Sci 2010; 40:8587.
  • 18
    Mazzarella G, Maglio M, Paparo F et al. An immunodominant DQ8 restricted gliadin peptide activates small intestinal immune response in in vitro cultured mucosa from HLA-DQ8 positive but not HLA-DQ8 negative coeliac patients. Gut 2003; 52:5762.
  • 19
    Tosco A, Maglio M, Paparo F et al. Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. J Pediatr Gastroenterol Nutr 2008; 47:293298.
  • 20
    Salmi TT, Collin P, Korponay-Szabó IR et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 2006; 55:17461753.
  • 21
    Troncone R, Jabri B. Coeliac disease and gluten sensitivity. J Intern Med 2011; 269:582590.
  • 22
    Not T, Ziberna F, Vatta S et al. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut 2011; 60:14871493.
  • 23
    Picarelli A, Sabbatella L, Di Tola M et al. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production. Am J Gastroenterol 2002; 97:9598.
    Direct Link:
  • 24
    Mawhinney H, Love AH. Anti-reticulin antibody in jejunal juice in coeliac disease. Clin Exp Immunol 1975; 21:394398.
  • 25
    Kappler M, Krauss-Etschmann S, Diehl V et al. Detection of secretory IgA antibodies against gliadin and human tissue transglutaminase in stool to screen for coeliac disease in children: validation study. BMJ 2006; 332:213214.
  • 26
    Di Niro R, Mesin L, Zheng NY et al. High abundance of plasma cells secreting transglutaminase 2-specific IgA autoantibodies with limited somatic hypermutation in celiac disease intestinal lesions. Nat Med 2012; 26:441445.
  • 27
    Salmi TT, Collin P, Jarvinen O et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther 2006; 24:541552.
  • 28
    Wahnschaffe U, Schulzke JD, Zeitz M et al. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007; 5:844850.
  • 29
    Maglio M, Florian F, Vecchiet M et al. Majority of children with type 1 diabetes produce and deposit anti-tissue transglutaminase antibodies in the small intestine. Diabetes 2009; 58:15781584.
  • 30
    Volta U, Tovoli F, Cicola R et al. Serological tests in gluten sensitivity (nonceliac gluten intolerance). J Clin Gastroenterol 2012; 46:680685.